αVEGFR2-MICA fusion antibodies enhance immunotherapy effect and synergize with PD-1 blockade.
Pan M, Wang F, Nan L, Yang S, Qi J, Xie J, Shao S, Zou H, Wang M, Sun F, Zhang J.
Pan M, et al. Among authors: wang f, wang m.
Cancer Immunol Immunother. 2023 Apr;72(4):969-984. doi: 10.1007/s00262-022-03306-1. Epub 2022 Oct 13.
Cancer Immunol Immunother. 2023.
PMID: 36227341
Free PMC article.